Could Weight Loss Drugs Turn Fat Cats Into Svelte Ozempets?news2025-12-02T10:04:46+00:00December 2nd, 2025|The New York Times|
Eli Lilly, Drug Maker of Zepbound and Mounjaro, Reaches $1 Trillion in Valuenews2025-11-21T21:25:40+00:00November 21st, 2025|The New York Times|
RFK Jr. Walks a Tightrope on Trump Deal for Obesity Drugsnews2025-11-14T10:02:07+00:00November 14th, 2025|The New York Times|
Cardiovascular Benefits of Wegovy Extend Beyond Weight Loss, Study Showsnews2025-10-22T22:30:06+00:00October 22nd, 2025|The New York Times|
America First? Not When It Comes to Your Health.news2025-08-24T09:55:00+00:00August 24th, 2025|The New York Times|
How Drinking Alcohol Affects You in Older Agenews2025-07-03T09:00:47+00:00July 3rd, 2025|The New York Times|
People With Severe Diabetes Are Cured in Small Trial of New Drugnews2025-06-20T23:38:23+00:00June 20th, 2025|The New York Times|
What to Know About Eli Lilly’s Daily Pill for Weight Lossnews2025-04-17T21:24:51+00:00April 17th, 2025|The New York Times|
F.D.A. Approves Ozempic to Treat Kidney Diseasenews2025-01-28T21:00:58+00:00January 28th, 2025|The New York Times|
